Q1 2020 Revance Therapeutics Inc Earnings Call Transcript
Welcome to the Revance Therapeutics First Quarter 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions) As a reminder, this call is being recorded today, May 7, 2020.
I would now like to turn the conference over to Jeanie Herbert, Senior Director of Investor Relations and Corporate Communications of Revance. Please go ahead, ma'am.
Thank you, Stacy. Joining us on the call today from Revance is President and Chief Executive Officer, Mark Foley; Chief Financial Officer, Toby Schilke; Chief Operating Officer and President of R&D and Product Operations, Dr. Abhay Joshi; and Chief Commercial Officer of Aesthetics and Therapeutics, Dustin Sjuts.
Earlier today, Revance released financial results for the first quarter ended March 31, 2020. If you've not received this news release or you would like to be added to the company's distribution list to receive future releases, please go to the Investor Relations section of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |